Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess pop...
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Taylor & Francis Group
2022-11-01
|
| Sarja: | Human Vaccines & Immunotherapeutics |
| Aiheet: | |
| Linkit: | http://dx.doi.org/10.1080/21645515.2022.2096375 |